Literature DB >> 499317

Prazosin, pharmacokinetics and concentration effect.

D N Bateman, D C Hobbs, T M Twomey, E A Stevens, M D Rawlins.   

Abstract

The pharmacokinetics and effects of prazosin have been studied after intravenous and oral dosing (1 mg) to 6 normal male volunteers. The mean terminal (beta) half-life was 2.9 h after intravenous and oral routes. Oral bioavailability was 56.9%. The effects of prazosin on blood pressure were more pronounced after intravenous than oral administration, and the hypotensive effect greater on erect blood pressure. There was a significant correlation (P less than 0.02) between the fall in blood pressure and the plasma drug concentration after intravenous prazosin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499317     DOI: 10.1007/bf00562058

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

Review 1.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

2.  Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

Authors:  A J Wood; P Bolli; F O Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

3.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.

Authors:  R R Miller; N A Awan; K S Maxwell; D T Mason
Journal:  N Engl J Med       Date:  1977-08-11       Impact factor: 91.245

4.  A random-zero sphygmomanometer.

Authors:  B M Wright; C F Dore
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

5.  Prazosin: the first-dose phenomenon.

Authors:  R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal:  Br Med J       Date:  1976-11-27

6.  Analysis of prazosin in plasma by a sensitive high-performance liquid chromatographic-fluorescence method.

Authors:  T M Twomey; D C Hobbs
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

7.  Pharmacokinetics of prazosin in man.

Authors:  D C Hobbs; T M Twomey; R F Palmer
Journal:  J Clin Pharmacol       Date:  1978 Aug-Sep       Impact factor: 3.126

8.  The metabolic fate of prazosin.

Authors:  J A Taylor; T M Twomey; M S von Wittenau
Journal:  Xenobiotica       Date:  1977-06       Impact factor: 1.908

  8 in total
  27 in total

1.  Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.

Authors:  R F Schafers; H L Elliott; P A Meredith; S H Miller; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

2.  Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.

Authors:  M G Scott; A H Deering; M T McMahon; D W Harron; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

4.  A pharmacokinetic study of prazosin in patients with varying degrees of chronic renal failure.

Authors:  N Lameire; J Gordts
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects.

Authors:  D M Pierce; S M Abrams; R A Franklin
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers.

Authors:  H M Norbury; R A Franklin; P K Marrott; S J Warrington
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  The effect of a single oral dose of prazosin on venous reflex response, blood pressure and pulse rate in normal volunteers.

Authors:  G J Schapel; W H Betts
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

8.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.

Authors:  J S Gutkind; M Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

10.  The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration.

Authors:  Thomas N Greenwell; Brendan M Walker; Pietro Cottone; Eric P Zorrilla; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2008-07-23       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.